The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Journal: Immunity

Published: 2020-04-14

DOI: 10.1016/j.immuni.2020.03.004

Affiliations: 10

Authors: 24

Go to article
Institutions Share
Department of Immunology, MOFFITT, United States of America (USA) 0.67
Department of Molecular Oncology, MOFFITT, United States of America (USA) 0.08
Bristol-Myers Squibb (BMS), United States of America (USA) 0.04
Center for Microbial Pathogenesis, Nationwide Children’s Hospital, United States of America (USA) 0.04
Institute of Translational Research (ITR), Ochsner Health System, United States of America (USA) 0.04
Department of Surgery, MUSC, United States of America (USA) 0.04
Department of Pediatrics, Augusta University, United States of America (USA) 0.02
Georgia Cancer Center, Augusta University, United States of America (USA) 0.02
Department of Obstetrics and Gynecology, Cornell University, United States of America (USA) 0.02
Sandra and Edward Meyer Cancer Center, Cornell University, United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER